Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nandhini Gangadaran
Institution:
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Observed institution:
Sanjay Gandhi Post Graduate Institute of Medical Sciences
ORCID:
0009-0006-2011-4760
Observed ORCID:
0009-0006-2011-4760
OpenAlex ID:
A5118114990
Real‐World Outcomes With Low‐Dose Dasatinib (50 mg) in Imatinib‐Resistant Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Analysis of Efficacy and Safety
2026
·
Nandhini Gangadaran
, Harshal Mamlekar
, et al.
·
Cancer Reports
·
2
PDF
Clinical profile and treatment outcomes in paediatric and adult acute promyelocytic leukemia: experience from a tertiary care centre in Northern India
2025
·
Harshal Mamlekar
, Nandhini Gangadaran
, et al.
·
Annals of Hematology
·
2
PDF
Pure Red Cell Aplasia in a Tropical Setting: A Comprehensive Etiological Profiling of the Largest Cohort from South Asia
2025
·
Nandhini Gangadaran
, Harshal Mamlekar
, et al.
·
Indian Journal of Hematology and Blood Transfusion
Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias in India: Clinical Characteristics, Outcomes and Relapse Predictors
2025
·
Harshal Mamlekar
, Sanjeev
, et al.
·
Indian Journal of Hematology and Blood Transfusion
Show more works
View as search
Works count:
4
Citation count:
4
H-index:
2
I10-index:
Year
Topic
Type